{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:27:44Z","timestamp":1756384064593},"reference-count":11,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.reuma.2016.10.008","type":"journal-article","created":{"date-parts":[[2016,12,29]],"date-time":"2016-12-29T12:20:22Z","timestamp":1483014022000},"page":"168-170","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Necrotizing fasciitis in a patient receiving tocilizumab for rheumatoid arthritis \u2013 Case report"],"prefix":"10.1016","volume":"14","author":[{"given":"Diana","family":"Rosa-Gon\u00e7alves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Bernardes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00facia","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2016.10.008_bib0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1517\/14740338.2011.537256","article-title":"Clinical safety of tocilizumab in rheumatoid arthritis","volume":"10","author":"Bannwarth","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.reuma.2016.10.008_bib0065","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/rheumatology\/keq343","article-title":"Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials","volume":"50","author":"Campbell","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.reuma.2016.10.008_bib0070","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/s10165-011-0505-9","article-title":"Necrotizing fasciitis in a patient with rheumatoid arthritis treated with tocilizumab","volume":"22","author":"Yoshida","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.reuma.2016.10.008_bib0075","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/rheumatology\/ker336","article-title":"Necrotizing fasciitis in a rheumatoid arthritis patient treated with tocilizumab","volume":"51","author":"van de Sande","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.reuma.2016.10.008_bib0080","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2340\/00015555-1952","article-title":"Development of necrotising fasciitis in a patient treated for rheumatoid arthritis with tocilizumab","volume":"95","author":"Hashimoto","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.reuma.2016.10.008_bib0085","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/1752-1947-4-367","article-title":"Necrotising fasciitis of the shoulder in association with rheumatoid arthritis treated with etanercept: a case report","volume":"4","author":"Smyth","year":"2010","journal-title":"Med Case Rep"},{"key":"10.1016\/j.reuma.2016.10.008_bib0090","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/pmj.78.915.47","article-title":"Necrotising fasciitis in a patient receiving infliximab for rheumatoid arthritis","volume":"78","author":"Chan","year":"2002","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.reuma.2016.10.008_bib0095","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0025-6196(11)62418-X","article-title":"Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept","volume":"76","author":"Baghai","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.reuma.2016.10.008_bib0100","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1002\/acr.22096","article-title":"Cutaneous adverse events during treatment of chronic inflammatory rheumatic conditions with tumor necrosis factor antagonists: study using the Spanish registry of adverse events of biological therapies in rheumatic diseases","volume":"65","author":"Hern\u00e1ndez MV1","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.reuma.2016.10.008_bib0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/annrheumdis-2011-201108","article-title":"Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register","volume":"72","author":"Galloway","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2016.10.008_bib0110","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/rheumatology\/ker223","article-title":"Risk of infections in rheumatoid arthritis patients treated with tocilizumab","volume":"51","author":"Lang","year":"2012","journal-title":"Rheumatology (Oxford)"}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X16301528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X16301528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T08:50:23Z","timestamp":1536137423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X16301528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1699258X16301528"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2016.10.008","relation":{},"ISSN":["1699-258X"],"issn-type":[{"value":"1699-258X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Necrotizing fasciitis in a patient receiving tocilizumab for rheumatoid arthritis \u2013 Case report","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2016.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}